Loading…

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction

It has been suggested that increased platelet activation increases the risk of acute myocardial infarction (AMI) in patients with depression. Selective serotonin reuptake inhibitors (SSRIs) may attenuate platelet activation by serotonin depletion in platelets. Observational studies have shown discre...

Full description

Saved in:
Bibliographic Details
Published in:Drug safety 2004-01, Vol.27 (14), p.1157-1165
Main Authors: SCHLIENFER, Raymond G, FISCHER, Lorenz M, JICK, Hershel, MEIER, Christoph R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It has been suggested that increased platelet activation increases the risk of acute myocardial infarction (AMI) in patients with depression. Selective serotonin reuptake inhibitors (SSRIs) may attenuate platelet activation by serotonin depletion in platelets. Observational studies have shown discrepant results of AMI risk associated with the use of SSRIs. The aim of this study was to evaluate the association of exposure to different groups of antidepressants, including SSRIs, and the risk of AMI. The study also assessed in more detail the influence of timing of the exposure to antidepressants in a general adult population (
ISSN:0114-5916
DOI:10.2165/00002018-200427140-00006